(Q36642111)

15 August 2017

1 reference

title

Place of peritoneal dialysis in the management of treatment-resistant congestive heart failure (English)

1 reference

15 August 2017

0 references

1 reference

1 reference

congestive heart failure

1 reference

Mehrotra R

1

1 reference

15 August 2017

Kathuria P

series ordinal

2

1 reference

15 August 2017

publication date

1 November 2006

1 reference

Kidney International. Supplement

15 August 2017

published in

1 reference

15 August 2017

issue

103

1 reference

15 August 2017

page(s)

S67-71

1 reference

Peritoneal ultrafiltration for chronic congestive heart failure: rationale, evidence and future

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

The association among renal insufficiency, pharmacotherapy, and outcomes in 6,427 patients with heart failure and coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

The prognostic importance of different definitions of worsening renal function in congestive heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

The renin-angiotensin-aldosterone system: cardiorenal effects and implications for renal and cardiovascular disease states

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Neurohormonal activation in congestive heart failure and the role of vasopressin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

The cardiorenal syndrome: lessons from the ADHERE database and treatment options

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Pathophysiologic targets in the early phase of acute heart failure syndromes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Cardio-renal insufficiency: the search for management strategies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Raised venous pressure: a direct cause of renal sodium retention in oedema?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Inotropic therapy for heart failure: an evidence-based approach.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

HFSA 2006 Comprehensive Heart Failure Practice Guideline.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

The effect of cardiac resynchronization on morbidity and mortality in heart failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

1 reference

7 January 2021

Simulations of peritoneal solute transport during CAPD. Application of two-pore formalism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Computer simulations of peritoneal fluid transport in CAPD.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Contribution of lymphatic absorption to loss of ultrafiltration and solute clearances in continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

The kinetics of ultrafiltration during peritoneal dialysis: the role of lymphatics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Peritoneal sodium transport during hypertonic peritoneal dialysis. Physiologic mechanisms and clinical implications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Treatment of malnutrition with 1.1% amino acid peritoneal dialysis solution: results of a multicenter outpatient study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Peritoneal transport characteristics with glucose polymer based dialysate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Continuous peritoneal irrigation in the treatment of intractable edema of cardiac origin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Clinical and hemodynamic results of peritoneal dialysis for severe cardiac failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Peritoneal dialysis for intractable heart failure in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Early ultrafiltration in patients with decompensated heart failure and diuretic resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Cardiorenal failure: treatment of refractory biventricular failure by peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Peritoneal ultrafiltration and treatment-resistant heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Continuous ambulatory peritoneal dialysis as treatment of severe congestive heart failure in the face of chronic renal failure. Report of eight cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Long-term successful management of refractory congestive cardiac failure by intermittent ambulatory peritoneal ultrafiltration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Peritoneal dialysis in refractory end-stage congestive heart failure: a challenge facing a no-win situation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

CAPD to improve quality of life in patients with refractory heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

The role of peritoneal dialysis in the treatment of refractory heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5001918

7 January 2021

Dimensions Publication ID

Identifiers

DOI

10.1038/SJ.KI.5001918

0 references

1016271265

0 references

1 reference